minutes of that March 13, 2020 meeting suggest that BMGF knew the proper drug dosing and the need for early administration. Yet their same researchers then participated in deliberately providing a potentially lethal dose, failing to dose by weight, missing the early window during which treatment was known to be effective, and giving the drug to subjects who were already critically ill with comorbidities that made it more likely they would not tolerate the high dose.
